Cargando…
P1318: THE IMPACT OF MELPHALAN DOSING IN COMBINATION WITH FLUDARABINE IN CLINICAL OUTCOMES OF PATIENTS WITH ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROMES RECEIVING ALLO-HCT
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431304/ http://dx.doi.org/10.1097/01.HS9.0000848136.92177.cc |
| _version_ | 1784780017391108096 |
|---|---|
| author | Albanyan, O. Kalos, D. Kim, J. Faramand, R. Elmariah, H. Mishra, A. Nishihori, T. Perez, L. Nieder, M. Pidala, J. Bejnayan, N. |
| author_facet | Albanyan, O. Kalos, D. Kim, J. Faramand, R. Elmariah, H. Mishra, A. Nishihori, T. Perez, L. Nieder, M. Pidala, J. Bejnayan, N. |
| author_sort | Albanyan, O. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9431304 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94313042022-08-31 P1318: THE IMPACT OF MELPHALAN DOSING IN COMBINATION WITH FLUDARABINE IN CLINICAL OUTCOMES OF PATIENTS WITH ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROMES RECEIVING ALLO-HCT Albanyan, O. Kalos, D. Kim, J. Faramand, R. Elmariah, H. Mishra, A. Nishihori, T. Perez, L. Nieder, M. Pidala, J. Bejnayan, N. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431304/ http://dx.doi.org/10.1097/01.HS9.0000848136.92177.cc Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Albanyan, O. Kalos, D. Kim, J. Faramand, R. Elmariah, H. Mishra, A. Nishihori, T. Perez, L. Nieder, M. Pidala, J. Bejnayan, N. P1318: THE IMPACT OF MELPHALAN DOSING IN COMBINATION WITH FLUDARABINE IN CLINICAL OUTCOMES OF PATIENTS WITH ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROMES RECEIVING ALLO-HCT |
| title | P1318: THE IMPACT OF MELPHALAN DOSING IN COMBINATION WITH FLUDARABINE IN CLINICAL OUTCOMES OF PATIENTS WITH ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROMES RECEIVING ALLO-HCT |
| title_full | P1318: THE IMPACT OF MELPHALAN DOSING IN COMBINATION WITH FLUDARABINE IN CLINICAL OUTCOMES OF PATIENTS WITH ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROMES RECEIVING ALLO-HCT |
| title_fullStr | P1318: THE IMPACT OF MELPHALAN DOSING IN COMBINATION WITH FLUDARABINE IN CLINICAL OUTCOMES OF PATIENTS WITH ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROMES RECEIVING ALLO-HCT |
| title_full_unstemmed | P1318: THE IMPACT OF MELPHALAN DOSING IN COMBINATION WITH FLUDARABINE IN CLINICAL OUTCOMES OF PATIENTS WITH ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROMES RECEIVING ALLO-HCT |
| title_short | P1318: THE IMPACT OF MELPHALAN DOSING IN COMBINATION WITH FLUDARABINE IN CLINICAL OUTCOMES OF PATIENTS WITH ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROMES RECEIVING ALLO-HCT |
| title_sort | p1318: the impact of melphalan dosing in combination with fludarabine in clinical outcomes of patients with acute myeloid leukemia and myelodysplastic syndromes receiving allo-hct |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431304/ http://dx.doi.org/10.1097/01.HS9.0000848136.92177.cc |
| work_keys_str_mv | AT albanyano p1318theimpactofmelphalandosingincombinationwithfludarabineinclinicaloutcomesofpatientswithacutemyeloidleukemiaandmyelodysplasticsyndromesreceivingallohct AT kalosd p1318theimpactofmelphalandosingincombinationwithfludarabineinclinicaloutcomesofpatientswithacutemyeloidleukemiaandmyelodysplasticsyndromesreceivingallohct AT kimj p1318theimpactofmelphalandosingincombinationwithfludarabineinclinicaloutcomesofpatientswithacutemyeloidleukemiaandmyelodysplasticsyndromesreceivingallohct AT faramandr p1318theimpactofmelphalandosingincombinationwithfludarabineinclinicaloutcomesofpatientswithacutemyeloidleukemiaandmyelodysplasticsyndromesreceivingallohct AT elmariahh p1318theimpactofmelphalandosingincombinationwithfludarabineinclinicaloutcomesofpatientswithacutemyeloidleukemiaandmyelodysplasticsyndromesreceivingallohct AT mishraa p1318theimpactofmelphalandosingincombinationwithfludarabineinclinicaloutcomesofpatientswithacutemyeloidleukemiaandmyelodysplasticsyndromesreceivingallohct AT nishihorit p1318theimpactofmelphalandosingincombinationwithfludarabineinclinicaloutcomesofpatientswithacutemyeloidleukemiaandmyelodysplasticsyndromesreceivingallohct AT perezl p1318theimpactofmelphalandosingincombinationwithfludarabineinclinicaloutcomesofpatientswithacutemyeloidleukemiaandmyelodysplasticsyndromesreceivingallohct AT niederm p1318theimpactofmelphalandosingincombinationwithfludarabineinclinicaloutcomesofpatientswithacutemyeloidleukemiaandmyelodysplasticsyndromesreceivingallohct AT pidalaj p1318theimpactofmelphalandosingincombinationwithfludarabineinclinicaloutcomesofpatientswithacutemyeloidleukemiaandmyelodysplasticsyndromesreceivingallohct AT bejnayann p1318theimpactofmelphalandosingincombinationwithfludarabineinclinicaloutcomesofpatientswithacutemyeloidleukemiaandmyelodysplasticsyndromesreceivingallohct |